LFT

Rating neutralAI MemoPost-earnings T+3

Lument Finance Trust

As of 2026-08-13/Post-earnings T+3/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-08-13 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

neutral

Confidence

medium

Horizon

—

Key catalyst

Q2 2026 filing and investor call will test dividend coverage • 2026-08-14

Base target: $1 / p=50% prob

Biggest risk

The NYSE deficiency, weak Q1 dividend coverage, and unresolved credit and financing uncertainty leave meaningful downside if the Q2 filing disappoints or a reverse split becomes more likely. Analyst revision evidence is unavailable.

Invalidation

Break below $0 or thesis failure.

What would change my mind?

A better Q2 result, maintained dividend, and improving credit or financing conditions could support a recovery from distressed trading levels.

Research note

Recommendation

neutral

Confidence

medium

As of

2026-08-13

Base target

p=50%

Bull target

p=20%

Bear target

p=30%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

NYSE minimum-price deficiency creates continued overhang
Credit and financing normalization could support rerating
A better Q2 result, maintained dividend, and improving credit or financing conditions could support a recovery from distressed trading levels.

BearKey bullets

Credit losses, liquidity, leverage, and financing compliance remain material risks, while the packet lacks a clean Q2 operating update.
NYSE continued-listing deficiency with a possible reverse stock split and a January 24, 2027 cure deadline [#IR-2026-07-30].
Q1 distributable earnings were $0.02 per share against a $0.04 common dividend, leaving coverage dependent on the Q2 update [#SEC-8K-2026-05-20] [#PR-EARNINGS-2026-06-10].

WatchKey bullets

Q2 2026 filing and investor call will test dividend coverage

Summary

High-level snapshot

Recommendation

neutral

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Post-earnings T+3

Base case: $1 (p=50%)

Target spread vs base: +36% / -43%

Scenario probabilities

Bull Target: $1 (p=20%)Base Target: $1 (p=50%)Bear Target: $0 (p=30%)

Commentary

News flow is sparse and primarily focused on the Q2 reporting schedule, dividend continuity, and the NYSE price deficiency. As of August 13, the Q2 results and post-print market reaction were not yet available; analyst target or estimate revisions were also unavailable. Social, options, short-interest, and employee data are absent, so these fields should not be treated as positive evidence.

As of 2026-08-13 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

A better Q2 result, maintained dividend, and improving credit or financing conditions could support a recovery from distressed trading levels.

Bear Case

Drivers

Scannable catalysts and supporting factors

NYSE minimum-price deficiency creates continued overhang
Credit and financing normalization could support rerating

Scenarios

Bull Target (Scenario probability)

$1 / p=20% prob

Base Target (Scenario probability)

$1 / p=50% prob

Bear Target (Scenario probability)

$0 / p=30% prob

Analysis 2026-08-13 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

-0.25

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-08-14
Q2 2026 filing and investor call will test dividend coverage
The company expects to file its June 30, 2026 Form 10-Q after market close on August 13 and hold its investor call on August 14. The key question is whether distributable earnings improved from Q1's $0.02 per share versus the $0.04 common dividend [#IR-2026-08-10] [#SEC-8K-2026-05-20].
Prob 100.00% • Move -4.00% • Priced-in 75.00%

Short-term Catalysts

Next few weeks

NYSE minimum-price deficiency creates continued overhang
2027-01-24
LFT disclosed that its average closing price was below $1 over 30 trading days. The six-month cure period ends January 24, 2027, and management is considering alternatives including a possible reverse stock split [#IR-2026-07-30] [#8-K-2026-07-30].
Prob 95% • Move -12% • Priced-in 70%

Long-term Catalysts

Months to a year

Credit and financing normalization could support rerating
2027-01-24
A durable recovery would require clearer evidence of asset-quality stabilization, financing compliance, and sustainable dividend coverage. Current evidence does not yet establish that recovery, so this remains a low-probability monitoring scenario [#10-Q-2026-05-15].
Prob 30% • Move 28% • Priced-in 25%

Risks

Credit losses, liquidity, leverage, and financing compliance remain material risks, while the packet lacks a clean Q2 operating update.
NYSE continued-listing deficiency with a possible reverse stock split and a January 24, 2027 cure deadline [#IR-2026-07-30].
Q1 distributable earnings were $0.02 per share against a $0.04 common dividend, leaving coverage dependent on the Q2 update [#SEC-8K-2026-05-20] [#PR-EARNINGS-2026-06-10].
Thin analyst, social, options, short-interest, and employee-sentiment coverage limits confidence in market expectations.

Peers

Symbol	Summary
LOAN	Manhattan Bridge Capital is the closest available small-cap real-estate lender comparison for payout and credit discipline, but it is not a direct mortgage-REIT match; peer read-through is limited.
HGBL	Heritage Global is a same-sector market-cap candidate but not a direct operating peer, providing little support for an LFT valuation thesis.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-08-13

Loading AI feed…

Symbol

Summary

LOAN

Manhattan Bridge Capital is the closest available small-cap real-estate lender comparison for payout and credit discipline, but it is not a direct mortgage-REIT match; peer read-through is limited.

HGBL

Heritage Global is a same-sector market-cap candidate but not a direct operating peer, providing little support for an LFT valuation thesis.